Response | Remission | Depressive symptoms | Quality of life3 | Dropout | ||
---|---|---|---|---|---|---|
BR (95% CI) | BR (95% CI) | short term1 | long term2 | SMD (95% CI) | OR (95% CI) | |
SMD (95% CI) | ||||||
Browne 2002 | 0.97 (0.81,1.16) | 0.94 (0.71,1.25) | −0.07 (−0.27,0.13) | 0.04 (−0.16,0.24) | 0.03 (−0.17,0.23) | 0.98 (0.59,1.64) |
deMello 2001 | 1.37 (0.98,1.91) | 1.45 (0.81,2.59) | 0.48 (−0.34,1.30) | 0.50 (−0.38,1.38) | 0.65 (−0.17,1.47) | 0.44 (0.11,1.70) |
Keller 2000 | 1.56 (1.33,1.84) | 2.07 (1.46,2.95) | 0.54 (0.19,0.89) | not reported | 0.29 (0.11,0.47) | 0.76 (0.49,1.17) |
Kocsis (CBASP) 2009 | 1.07 (0.67,1.70) | 1.11 (0.67,1.84) | 0.12 (−0.23,0.47) | not reported | 0.22 (−0.13,0.57) | 0.71 (0.30,1.70) |
Kocsis (BSP) 2009 | 0.85 (0.53,1.38) | 0.91 (0.54,1.54) | −0.06 (−0.41,0.29) | not reported | 0.07 (−0.28,0.42) | 0.80 (0.34,1.90) |
Markowitz 2005 | 0.98 (0.59,1.62) | 1.26 (0.67,2.35) | −0.27 (−0.86,0.32) | not reported | 0.22 (−0.37,0.81) | 0.89 (0.21,3.88) |
Miller 1999 | 11.27 (0.70,181.41) | 1.29 (0.47,3.51) | 4.15 (2.78,5.52) | 0.10 (−0.66,0.86) | 1.15 (0.33,1.97) | 1.36 (0.19,9.91) |
Ravindran 1999 | 1.25 (0.78,1.99) | 1.06 (0.57,1.95) | 0.05 (−0.54,0.64) | not reported | 0.15 (−0.54,0.84) | not estimable |
Schramm 2008 | 1.86 (1.02,3.40) | 1.75 (0.80,3.84) | 0.53 (−0.06,1.12) | 0.63 (−0.06,1.32) | not reported | 3.17 (0.56,17.78) |
total | ||||||
overall effect * | 1.20 (0.98,1.48) | 1.25 (0.97,1.61) | 0.13 (−0.08,0.34) | 0.25 (−0.15,0.66) | 0.18 (0.07,0.29) | 0.84 (0.64,1.11) |
p for overall effect * | 0.080 | 0.080 | 0.220 | 0.220 | 0.002 | 0.210 |
I² * | 67% | 52% | 50% | 42% | 0% | 0% |
p for heterogeneity * | 0.004 | 0.040 | 0.050 | 0.180 | 0.490 | 0.690 |